Denali Therapeutics, Inc. (DNLI)
21.09
-0.31
(-1.45%)
USD |
NASDAQ |
Sep 11, 16:00
21.08
-0.01
(-0.05%)
After-Hours: 20:00
Denali Therapeutics Price : 21.09 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 21.65 | 21.79 | 21.06 | 21.09 | 1.240M |
| Sep 10, 2026 | 21.24 | 21.58 | 21.09 | 21.40 | 938559.0 |
| Sep 09, 2026 | 21.69 | 22.06 | 21.34 | 21.57 | 2.092M |
| Sep 08, 2026 | 21.79 | 22.25 | 21.66 | 22.08 | 1.654M |
| Sep 04, 2026 | 22.32 | 22.48 | 22.14 | 22.28 | 799634.0 |
| Sep 03, 2026 | 23.00 | 23.02 | 22.35 | 22.80 | 1.728M |
| Sep 02, 2026 | 23.33 | 23.86 | 22.53 | 22.85 | 1.769M |
| Sep 01, 2026 | 23.44 | 23.75 | 23.06 | 23.26 | 1.432M |
| Aug 31, 2026 | 23.72 | 24.01 | 23.41 | 23.76 | 985862.0 |
| Aug 28, 2026 | 24.42 | 24.62 | 23.92 | 24.00 | 807598.0 |
| Aug 27, 2026 | 24.43 | 24.74 | 24.16 | 24.67 | 700115.0 |
| Aug 26, 2026 | 24.75 | 24.89 | 24.33 | 24.57 | 771265.0 |
| Aug 25, 2026 | 24.86 | 25.26 | 24.81 | 24.93 | 1.121M |
| Aug 24, 2026 | 24.88 | 25.27 | 23.41 | 24.20 | 1.321M |
| Aug 21, 2026 | 25.25 | 25.37 | 24.60 | 24.92 | 680993.0 |
| Aug 20, 2026 | 25.15 | 25.60 | 24.65 | 24.95 | 976849.0 |
| Aug 19, 2026 | 25.00 | 25.70 | 24.61 | 25.69 | 1.150M |
| Aug 18, 2026 | 24.17 | 24.49 | 24.01 | 24.31 | 1.100M |
| Aug 17, 2026 | 24.29 | 24.66 | 24.11 | 24.35 | 1.003M |
| Aug 14, 2026 | 24.53 | 24.62 | 24.12 | 24.40 | 889995.0 |
| Aug 13, 2026 | 25.24 | 25.64 | 24.81 | 24.82 | 1.347M |
| Aug 12, 2026 | 24.51 | 25.34 | 24.20 | 25.27 | 1.442M |
| Aug 11, 2026 | 25.07 | 25.29 | 24.59 | 24.69 | 1.145M |
| Aug 10, 2026 | 24.71 | 25.04 | 24.21 | 25.00 | 1.563M |
| Aug 07, 2026 | 25.41 | 25.74 | 24.24 | 24.83 | 1.750M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 82.85 |
| Oncolytics Biotech, Inc. | 0.7455 |
| Sangamo Therapeutics, Inc. | 0.1485 |
| Sarepta Therapeutics, Inc. | 20.45 |
| Anixa Biosciences, Inc. | 2.76 |
Price Related Metrics
| PS Ratio | 1056.01 |
| PEG Ratio | -6.956 |
| Price to Book Value | 4.034 |
| Earnings Yield | -13.46% |
| Market Cap | 3.369B |
| PEGY Ratio | -6.956 |